Clinical Trial Update: Photobiomodulation for Breast Cancer Radiodermatitis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for photobiomodulation in breast cancer radiodermatitis shows completed Phase 2/Phase 3 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: AC Camargo Cancer Center | Conditions: Breast Cancer, Radiodermatitis | Phase 2, Phase 3 | Status: COMPLETED